WallStreetZenWallStreetZen

NASDAQ: FUSN
Fusion Pharmaceuticals Inc Stock Ownership - Who owns Fusion Pharmaceuticals?

Insider buying vs selling

Have Fusion Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when FUSN insiders and whales buy or sell their stock.

FUSN Shareholders

What type of owners hold Fusion Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc12.71%10,811,153$232.66MInstitution
Perceptive Advisors LLC8.02%6,825,395$146.88MInstitution
Avidity Partners Management LP7.64%6,500,328$139.89MInstitution
Deerfield Management Company LP Series C7.53%6,401,000$137.75MInstitution
Tpg Group Holdings Sbs Advisors Inc5.71%4,853,588$104.45MInsider
Fil Ltd4.92%4,187,271$90.11MInstitution
Johan Christenson4.48%3,807,247$81.93MInsider
Healthcap Vii LP4.48%3,807,247$81.93MInsider
Pentwater Capital Management LP4.45%3,781,778$81.38MInstitution
Johnson Johnson4.32%3,670,516$78.99MInsider

1 of 3

FUSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FUSN73.75%26.25%
GLPG30.89%0.00%
ZLAB4.16%1.96%Net BuyingNet Buying
CPRX81.35%16.30%Net BuyingNet Selling
RCKT55.68%44.32%Net SellingNet Selling

Fusion Pharmaceuticals Stock Ownership FAQ

Who owns Fusion Pharmaceuticals?

Fusion Pharmaceuticals (NASDAQ: FUSN) is owned by 81.22% institutional shareholders, 28.91% Fusion Pharmaceuticals insiders, and 0.00% retail investors. Tpg Group Holdings Sbs Advisors Inc is the largest individual Fusion Pharmaceuticals shareholder, owning 4.85M shares representing 5.71% of the company. Tpg Group Holdings Sbs Advisors Inc's Fusion Pharmaceuticals shares are currently valued at $104.45M.

If you're new to stock investing, here's how to buy Fusion Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.